ResMed Inc
RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3011% below fair value
$242.61+4.76 (+2.00%)
Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%
ResMed Global Devices by Year
Global Devices — Share of Trailing 12-Month Consolidated Revenue (%) (%)
Periods
ResMed Global Devices: 51.0% in FY2026, down 1.0 pts from a year earlier.
Latest, FY2026
51.0%
Period ended Jun 30, 2026 (CY2026)
Change on a year earlier
-1.0 pts
52.0% in FY2025
History
6 years
Since FY2021
Sources
6
Documents cited below
Where the FY2026 figure comes from
“pdates Performance Resmed | The global leader in connected and digital health Corporate Highlights TTM Financial Highlights Headquarters San Diego, CA Total HL revenue ~$5.7B 12%3 12%3 Founded 1989 CC Revenue YoY 8% Revenue Revenue growth 37% by business 50% 30% by region Listed (NYSE, Non-GAAP FY26 FY26 58% 1995, RMD Operating 36% ASX) margin Countries 1% 140+ Non-GAAP EPS served 17% YoY growth ▪ Sleep Devices ▪ Americas ▪ Life Support Devices ▪”
Source: ResMed Q4 FY2026 Company Overview Presentation (2026-09-15) ↗
Reported in ResMed Quarterly Earnings Presentations (At-a-Glance Business Mix).
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Global Devices — Share of Trailing 12-Month Consolidated Revenue (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2026CY2026 | Jun 30, 2026 | 51.0% | -1.0 pts | ResMed Q4 FY2026 Company Overview Presentation (2026-09-15) ↗ |
| FY2025CY2025 | Jun 30, 2025 | 52.0% | 0.0 pts | ResMed Q4 FY2025 Corporate Overview One-Pager (2025-07-31) ↗ |
| FY2024CY2024 | Jun 30, 2024 | 52.0% | -2.0 pts | ResMed Q4 FY2024 Corporate Overview One-Pager (2024-08-01) ↗ |
| FY2023CY2023 | Jun 30, 2023 | 54.0% | +2.0 pts | ResMed Q4 FY2023 Corporate Overview One-Pager (2023-08-03) ↗ |
| FY2022CY2022 | Jun 30, 2022 | 52.0% | +2.0 pts | ResMed Q4 FY2022 Corporate Overview One-Pager (2022-08-11) ↗ |
| FY2021CY2021 | Jun 30, 2021 | 50.0% | – | ResMed Q4 FY2021 Corporate Overview One-Pager (2021-08-05) ↗ |
Cite this data
StockData. (2026). ResMed Global Devices (%), annual FY2021–FY2026 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/dev-global-mix-ltm
See every metric in the ResMed KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?